Soleus Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Soleus Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-40,000	Closed	-$3.72M	–	84
2021 Q4	$3.72M	Sell	40,000 -16,800	-30%	-$1.11M	0.37%	45
2021 Q3	$3.38M	Buy	+56,800	New	+$3.36M	0.53%	45
2020 Q4	–	Sell	-10,977	Closed	-$821K	–	83
2020 Q3	$821K	Buy	+10,977	New	+$732K	0.44%	49
2020 Q1	–	Sell	-11,100	Closed	-$504K	–	63
2019 Q4	$504K	Buy	+11,100	New	+$525K	0.49%	36

Soleus Capital Management's ARNA Position: Q1 2022 in Review

Soleus Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 40,000 shares — an estimated $3.72M sold.

Soleus Capital Management first reported a position in ARNA in Q4 2019 and held it in 4 quarters. The position peaked at $3.72M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Soleus Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Soleus Capital Management sold 40,000 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $3.72M.
Soleus Capital Management first reported a position in Arena Pharmaceuticals Inc in Q4 2019 and held it in 4 quarters.
Soleus Capital Management's Arena Pharmaceuticals Inc position peaked at $3.72M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Soleus Capital Management's 13F filing for Q1 2022, filed 16 May 2022.